Physician profile
Vipul Reddy
NPI 1114668324
$691.54
in general payments reported to CMS, 2019-2025
8 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.28 · 2023: $23.61 · 2024: $324 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $241.41 | 2024-2025 | Farxiga, Lokelma |
| Inari Medical, INC. | $169.71 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $110.04 | 2025 | Extended Holter |
| Integra Lifesciences Corporation | $79.00 | 2022 | |
| Medtronic, INC. | $42.19 | 2023-2024 | Endurant Iis |
| Stryker Corporation | $19.62 | 2025 | Flowsaver |
| Kci USA, INC. | $15.28 | 2022 | |
| Amgen INC. | $14.29 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.